Search Results - "Hummersone M"

42 ATM and DNA-PK inhibitors: Functional significance, mechanism of action and clinical application

Authors: Slade, A. Batey, M. Curtin, N. et al.

Source: Radiotherapy & Oncology. Mar2006 Supplement 1, Vol. 78, pS15-S15. 1p.

N3-substituted temozolomide analogs overcome methylguanine-DNA methyltransferase and mismatch repair precipitating apoptotic and autophagic cancer cell death.

Authors: Zhang J Hummersone M Matthews CS et al.

Source: Oncology [Oncology] 2015; Vol. 88 (1), pp. 28-48. Date of Electronic Publication: 2014 Sep 26.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

Certain imidazotetrazines escape O6-methylguanine-DNA methyltransferase and mismatch repair.

Authors: Zhang J Stevens MF Hummersone M et al.

Source: Oncology [Oncology] 2011; Vol. 80 (3-4), pp. 195-207. Date of Electronic Publication: 2011 Jul 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

Erratum: identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.

Authors: Rizzo A Iachettini S Zizza P et al.

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2015 Feb 05; Vol. 34, pp. 9. Date of Electronic Publication: 2015 Feb 05.

Publication Type: Published Erratum

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: PubMed not MEDLINE

Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.

Authors: Rizzo A Iachettini S Zizza P et al.

Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2014 Oct 06; Vol. 33, pp. 81. Date of Electronic Publication: 2014 Oct 06.

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.

Authors: Chresta CM Davies BR Hickson I et al.

Source: Cancer research [Cancer Res] 2010 Jan 01; Vol. 70 (1), pp. 288-98. Date of Electronic Publication: 2009 Dec 22.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.

Authors: Malagu K Duggan H Menear K et al.

Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2009 Oct 15; Vol. 19 (20), pp. 5950-3. Date of Electronic Publication: 2009 Aug 13.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.

Authors: Golding SE Rosenberg E Valerie N et al.

Source: Molecular cancer therapeutics [Mol Cancer Ther] 2009 Oct; Vol. 8 (10), pp. 2894-902. Date of Electronic Publication: 2009 Oct 06.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Control of olefin geometry in the bryostatin B-ring through exploitation of a C(2)-symmetry breaking tactic and a Smith-Tietze coupling reaction.

Authors: Hale KJ Hummersone MG Bhatia GS

Source: Organic letters [Org Lett] 2000 Jul 27; Vol. 2 (15), pp. 2189-92.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 100890393 Publication Model: Print Cited Medium: Print ISSN: 1523-7060 (Print) Linking ISSN: 15237052 NLM ISO Abbreviation: Org Lett Subsets: MEDLINE